Amedisys’ High-Acuity, Non-Medicare Revenue Skyrockets As It Waits For UnitedHealth Group Deal To Close

Amedisys Inc. (Nasdaq: AMED) is waiting for multiple big-time transactions to come to fruition by year end. In the meantime, it continues to grow its non-Medicare revenue and its high-acuity care business considerably. The company released its second-quarter earnings on Wednesday, without an accompanying call. It has not held an official earnings call since UnitedHealth […]

Optum’s Home & Community Business Reportedly Hit With Layoffs

UnitedHealth Group’s (NYSE: UNH) Optum has reportedly conducted a round of layoffs, specifically within Landmark Health, which is an in-home medical care operator. Optum agreed to acquire Landmark Health early in 2021. Optum also acquired the in-home medical group Prospero Health early in 2023, rolling it into Landmark Health. While the layoffs are not isolated […]

Amedisys To Divest Certain Home Health Locations To VitalCaring, Clearing Path For UnitedHealth Group Deal

Amedisys Inc. (Nasdaq: AMED) filed paperwork Friday with the U.S. Securities and Exchange Commission saying it has agreed to divest “certain” locations to an affiliate of home health and hospice company VitalCaring. The divestiture was a way for Amedisys to avoid further antitrust concerns from regulators prior to it joining UnitedHealth Group (NYSE: UNH). UnitedHealth […]

What The Amedisys Divestment Snag Means For The Home Health Industry

As UnitedHealth Group (NYSE: UNH) and Amedisys (Nasdaq: AMED) work on a divestment strategy that will satisfy regulators, a lot hangs in the balance. For one, UnitedHealth Group and Optum’s deal for the home health and hospice provider Amedisys is one of the largest deals in the industry’s history, only trailing Optum’s deal for Amedisys’ […]

UnitedHealth Group Remains Under Duress From Change Healthcare Cyberattack, DOJ Investigation

It was a turbulent start to the year for the health care giant UnitedHealth Group, driven by the cyberattack on Change Healthcare and a U.S. Department of Justice (DOJ) antitrust investigation. Amid the DOJ investigation, UnitedHealth Group’s planned acquisition of the home health company Amedisys Inc. (Nasdaq: AMED) came into focus, with reports circulating that […]

Exploring What An Amedisys Divestment Strategy Could Look Like

UnitedHealth Group (NYSE: UNH) and Amedisys Inc. (Nasdaq: AMED) announced combination plans last June, under which home health giant Amedisys would become part of Optum. Amedisys had previously entered into an agreement to merge with infusion therapy company Option Care Health (Nasdaq: OPCH), but UnitedHealth Group’s offer, scale and complementary clinical capabilities were effectively too […]

The Most Game-Changing Home-Based Care Blockbusters Of The Last Decade

Thanks to impactful, large-scale transactions over the last decade, the collective face of home-based care has changed forever. Traditional providers in both home health care and personal home care have merged. Payers became involved in the home-based care space like never before. Of late, retailers have too. But it’s often easy to forget how the […]

DOJ Reportedly Considering Lawsuit To Block Optum-Amedisys Deal

UnitedHealth Group’s (NYSE:UNH) planned acquisition of Amedisys Inc. (Nasdaq:AMED) is catching further scrutiny. Late Wednesday, a report suggesting that the Department of Justice is considering a lawsuit to block Optum’s takeover of Amedisys surfaced. The deal was first agreed to in June of last year. The news comes just a few weeks after the DOJ […]

With Amedisys Deal Pending, Justice Department Opens Antitrust Investigation Into UnitedHealth Group

The Department of Justice is targeting UnitedHealth Group (NYSE: UNH) in an antitrust investigation, The Wall Street Journal reported Tuesday.  Specifically, the Justice Department is interviewing subjects around interactions between UnitedHealth Group and its health care provider services arm, Optum. UnitedHealthcare is one of the largest insurers in the country. Meanwhile, Optum is one of […]